Dana Lee

4.8k total citations
19 papers, 861 citations indexed

About

Dana Lee is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Dana Lee has authored 19 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Surgery. Recurrent topics in Dana Lee's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Child Nutrition and Feeding Issues (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). Dana Lee is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Child Nutrition and Feeding Issues (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). Dana Lee collaborates with scholars based in United States, Canada and France. Dana Lee's co-authors include Patrick Tso, J. Rosenberg, Antonio J Grillo-López, Marc A. Shuman, Kenneth Aldape, Lloyd E. Damon, Robert J. Ignoffo, James L. Rubenstein, Dan Combs and Michael McDermott and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Dana Lee

18 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Lee United States 11 253 245 241 176 170 19 861
Laisvyde Statkute United States 13 210 0.8× 230 0.9× 55 0.2× 92 0.5× 169 1.0× 24 1.1k
Roberto Bomprezzi United States 12 239 0.9× 396 1.6× 127 0.5× 123 0.7× 26 0.2× 24 973
Colette Roche France 18 104 0.4× 370 1.5× 152 0.6× 284 1.6× 22 0.1× 54 967
Berardino Porfirio Italy 19 89 0.4× 718 2.9× 159 0.7× 175 1.0× 48 0.3× 69 1.3k
Eric Chan China 13 81 0.3× 241 1.0× 98 0.4× 66 0.4× 33 0.2× 21 729
Mark J. Cooper Australia 18 64 0.3× 446 1.8× 215 0.9× 232 1.3× 24 0.1× 37 1.6k
Douangsone D. Vadysirisack United States 14 77 0.3× 755 3.1× 79 0.3× 193 1.1× 26 0.2× 20 1.6k
Junyu Wang China 19 46 0.2× 417 1.7× 203 0.8× 101 0.6× 84 0.5× 89 924
Laura Guarnaccia Italy 15 151 0.6× 262 1.1× 61 0.3× 59 0.3× 97 0.6× 28 635
Mariapia Cinelli Italy 15 49 0.2× 195 0.8× 45 0.2× 132 0.8× 47 0.3× 18 660

Countries citing papers authored by Dana Lee

Since Specialization
Citations

This map shows the geographic impact of Dana Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Lee more than expected).

Fields of papers citing papers by Dana Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Lee. The network helps show where Dana Lee may publish in the future.

Co-authorship network of co-authors of Dana Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Lee. A scholar is included among the top collaborators of Dana Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Lee. Dana Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Mieczkowski, Carl, Xuejin Zhang, Dana Lee, et al.. (2023). Blueprint for antibody biologics developability. mAbs. 15(1). 2185924–2185924. 30 indexed citations
3.
Wong, Shekman, Cecile M. Krejsa, Dana Lee, et al.. (2022). Pharmacokinetics and Macrophage Inhibitory Cytokine‐1 Pharmacodynamics of the Murine Double Minute 2 Inhibitor, Navtemadlin (KRT‐232) in Fed and Fasted Healthy Subjects. Clinical Pharmacology in Drug Development. 11(5). 640–653. 2 indexed citations
4.
Taylor, Adekemi, et al.. (2021). Phase 1 Concentration‐QTc and Cardiac Safety Analysis of the MDM2 Antagonist KRT‐232 in Patients With Advanced Solid Tumors, Multiple Myeloma, or Acute Myeloid Leukemia. Clinical Pharmacology in Drug Development. 10(8). 918–926. 11 indexed citations
5.
Wong, Shekman, Cecile M. Krejsa, Dana Lee, et al.. (2020). Effect of Food on MDM2 Inhibitor KRT-232 Pharmacokinetics and Macrophage Inhibitory Cytokine-1 (MIC-1) Response in Healthy Volunteers. Blood. 136(Supplement 1). 7–8. 1 indexed citations
7.
Tso, Patrick, et al.. (2018). Effect of mono- and diglycerides on the digestion and absorption of lutein in lymph fistula rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 315(1). G95–G103. 11 indexed citations
8.
Tso, Patrick, et al.. (2016). Evaluation of Different Delivery Vehicles on the Digestion and Absorption of Lutein using a Lymph Fistula Rat Model. The FASEB Journal. 30(S1). 2 indexed citations
9.
Kohan, Alison B., Qing Yang, Min Xu, Dana Lee, & Patrick Tso. (2016). Monosodium glutamate inhibits the lymphatic transport of lipids in the rat. American Journal of Physiology-Gastrointestinal and Liver Physiology. 311(4). G648–G654. 8 indexed citations
10.
Zippin, Jonathan H., Yanqiu Chen, Susanne G. Straub, et al.. (2014). CO2/HCO3−- and calcium-regulated soluble adenylyl cyclase as a physiological ATP sensor.. Journal of Biological Chemistry. 289(18). 12679–12679. 1 indexed citations
11.
Zippin, Jonathan H., Yanqiu Chen, Susanne G. Straub, et al.. (2013). CO2/HCO3−- and Calcium-regulated Soluble Adenylyl Cyclase as a Physiological ATP Sensor. Journal of Biological Chemistry. 288(46). 33283–33291. 101 indexed citations
12.
Lee, Dana, Shaun G. Goodman, Keith A.A. Fox, et al.. (2013). Prognostic significance of presenting blood pressure in non–ST-segment elevation acute coronary syndrome in relation to prior history of hypertension. American Heart Journal. 166(4). 716–722. 16 indexed citations
13.
Lu, Wendell J., Qing Yang, Li Yang, et al.. (2012). Chylomicron Formation and Secretion is Required for Lipid‐Stimulated Release of Incretins GLP‐1 and GIP. Lipids. 47(6). 571–580. 45 indexed citations
14.
Birnholtz, Jeremy, et al.. (2010). Automatic camera control using unobtrusive vision and audio tracking. Graphics Interface. 101(1). 47–54. 14 indexed citations
15.
Lo, Chunmin C., Brian K. Nordskog, Andromeda M. Nauli, et al.. (2007). Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(1). G344–G352. 62 indexed citations
16.
Nauli, Andromeda M., Fatiha Nassir, Shuqin Zheng, et al.. (2006). CD36 Is Important for Chylomicron Formation and Secretion and May Mediate Cholesterol Uptake in the Proximal Intestine. Gastroenterology. 131(4). 1197–1207. 153 indexed citations
17.
Lee, Dana, et al.. (2004). Analytical model for the programming of source side injection SST superflash split-gate cell using two-dimensional analysis. Solid-State Electronics. 48(12). 2199–2206. 2 indexed citations
18.
Rubenstein, James L., Dan Combs, J. Rosenberg, et al.. (2002). Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 101(2). 466–468. 327 indexed citations
19.
Wiklund, Tom, Juhani Collan, Rita Janes, et al.. (2001). Complement Activation in Circulation and Central Nervous System after Rituximab (Anti-CD20) Treatment of B-Cell Lymphoma. Leukemia & lymphoma. 42(4). 731–738. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026